Isaindigotone as an inhibitor of the lipopolysaccharide‑induced inflammatory reaction of BV‑2 cells and corresponding mechanisms

Xiao,Hui; Xu,Jianhua

doi:10.3892/mmr.2019.9909

Isaindigotone as an inhibitor of the lipopolysaccharide‑induced inflammatory reaction of BV‑2 cells and corresponding mechanisms

Authors:
- Hui Xiao
- Jianhua Xu
View Affiliations

Affiliations: Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China
Published online on: January 30, 2019 https://doi.org/10.3892/mmr.2019.9909
Pages: 2890-2896

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Isaindigotone possesses extensive pharmacological activities, including anti‑inflammatory effects. The present study investigated the role of isaindigotone in the inhibition of neuroinflammation. Mouse BV‑2 cells were incubated with lipopolysaccharide (LPS; 1 mg/l) for 24 h in a microglial inflammatory model in vitro. The effects of isaindigotone on BV‑2 cell proliferation were observed using the 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide method. Following co‑incubation, an enzyme‑linked immunosorbent assay and western blot analysis were used to analyze cellular levels of cytokines and associated protein expression, including the phosphorylation of nuclear factor (NF)‑κB. The effects of isaindigotone concentration on LPS‑mediated cell chemotaxis behavior were assessed using a chemotaxis assay. The results indicated that isaindigotone is non‑toxic towards BV‑2 cells. Compared with the LPS group, isaindigotone significantly reduced the secretion of tumor necrosis factor‑α and interleukin‑1β in BV‑2 cells and reduced the cell chemotaxis caused by LPS; it also reversed morphological changes in the BV‑2 cells and inhibited the phosphorylation of NF‑κB. The results of the present study suggest that isaindigotone can inhibit inflammatory reactions in LPS‑induced BV‑2 cells, and provides a theoretical basis and experimental evidence for examining the mechanism underlying the isaindigotone‑induced inhibition of neuroinflammation.

View Figures

View References

1	Savitz J and Harrison NA: Interoception and inflammation in psychiatric disorders. Biol Psychiatry Cogn Neurosci Neuroimaging. 3:514–524. 2018. View Article : Google Scholar : PubMed/NCBI
2	Branchford BR and Carpenter SL: The role of inflammation in venous thromboembolism. Front Pediatr. 6:1422018. View Article : Google Scholar : PubMed/NCBI
3	Gelders G, Baekelandt V and Van der Perren A: Linking neuroinflammation and neurodegeneration in parkinson's disease. J Immunol Res. 2018:47842682018. View Article : Google Scholar : PubMed/NCBI
4	Katsuki S, Matoba T, Koga JI, Nakano K and Egashira K: Anti-inflammatory nanomedicine for cardiovascular disease. Front Cardiovasc Med. 4:872017. View Article : Google Scholar : PubMed/NCBI
5	Escárcega RO, Lipinski MJ, García-Carrasco M, Mendoza-Pinto C, Galvez-Romero JL and Cervera R: Inflammation and atherosclerosis: Cardiovascular evaluation in patients with autoimmune diseases. Autoimmun Rev. 17:703–708. 2018. View Article : Google Scholar : PubMed/NCBI
6	Zhang C, Syed TW, Liu R and Yu J: Role of endoplasmic reticulum stress, autophagy, and inflammation in cardiovascular disease. Front Cardiovasc Med. 4:292017. View Article : Google Scholar : PubMed/NCBI
7	Bhatelia K, Singh K and Singh R: TLRs: Linking inflammation and breast cancer. Cell Signal. 26:2350–2357. 2014. View Article : Google Scholar : PubMed/NCBI
8	Valdés-Rives SA and González-Arenas A: Autotaxin-lysophosphatidic acid: From inflammation to cancer development. Mediators Inflamm. 2017:91730902017. View Article : Google Scholar : PubMed/NCBI
9	Qu X, Tang Y and Hua S: Immunological approaches towards cancer and inflammation: A cross talk. Front Immunol. 9:5632018. View Article : Google Scholar : PubMed/NCBI
10	Molina P, Tárraga A, Gonzalez-Tejero A, Rioja I, Ubeda A, Terencio MC and Alcaraz MJ: Inhibition of leukocyte functions by the alkaloid isaindigotone from Isatis indigotica and some new synthetic derivatives. J Nat Prod. 64:1297–1300. 2001. View Article : Google Scholar : PubMed/NCBI
11	Yan JW, Li YP, Ye WJ, Chen SB, Hou JQ, Tan JH, Ou TM, Li D, Gu LQ and Huang ZS: Design, synthesis and evaluation of isaindigotone derivatives as dual inhibitors for acetylcholinesterase and amyloid beta aggregation. Bioorg Med Chem. 20:2527–2534. 2012. View Article : Google Scholar : PubMed/NCBI
12	Shakhidoyatov KM and Elmuradov BZ: Tricyclic Quinazoline Alkaloids: Isolation, synthesis, chemical modification, and biological activity. Chem Nat Comp. 50:781–800. 2014. View Article : Google Scholar
13	Lei LM and Pang QP: Recent progress in the studies of chemistry, pharmacology, quality control and extraction methods on the Radix isatidis. Shi Zhen Guo Yi Guo Yao. 18:2578–2580. 2007.(In Chinese).
14	He LW, Liu HQ, Chen YQ, Yang JY, Wang TL and Li W: Total synthesis and anti-viral activities of an extract of Radix isatidis. Molecules. 19:20906–20912. 2014. View Article : Google Scholar : PubMed/NCBI
15	Zhou W and Zhang XY: Research progress of Chinese herbal medicine Radix isatidis (banlangen). Am J Chin Med. 41:743–764. 2013. View Article : Google Scholar : PubMed/NCBI
16	Pósfai B, Cserép C, Orsolits B and Dénes Á: New insights into microglia-neuron interactions: A neuron's perspective. Neuroscience. May 19–2018.(Epub ahead of print). View Article : Google Scholar
17	Sevenich L: Brain-resident microglia and blood-borne macrophages orchestrate central nervous system inflammation in neurodegenerative disorders and brain cancer. Front Immunol. 9:6972018. View Article : Google Scholar : PubMed/NCBI
18	Altmann C and Schmidt MHH: The role of microglia in diabetic retinopathy: Inflammation, microvasculature defects and neurodegeneration. Int J Mol Sci. 19:E1102018. View Article : Google Scholar : PubMed/NCBI
19	Olajide OA, Kumar A, Velagapudi R, Okorji UP and Fiebich BL: Punicalagin inhibits neuroinflammation in LPS-activated rat primary microglia. Mol Nutr Food Res Sep. 58:1843–1851. 2014. View Article : Google Scholar
20	Li Y, Lv O, Zhou F, Li Q, Wu Z and Zheng Y: Linalool inhibits LPS-induced inflammation in BV2 microglia cells by activating Nrf2. Neurochem Res. 40:1520–1525. 2015. View Article : Google Scholar : PubMed/NCBI
21	Wang WY, Tan MS, Yu JT and Tan L: Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease. Ann Transl Med. 3:1362015.PubMed/NCBI
22	Jiang Y, An Y, Jiang D, Wu B, Yang Y and Sun D: TNF-α regulating interleukin-33 induces acute pancreatic inflammation in rats. Ann Clin Lab Sci. 46:54–59. 2016.PubMed/NCBI
23	Bucher H, Mang S, Keck M, Przibilla M, Lamb DJ, Schiele F, Wittenbrink M, Fuchs K, Jung B, Erb KJ and Peter D: Neutralization of both IL-1α/IL-1β plays a major role in suppressing combined cigarette smoke/virus-induced pulmonary inflammation in mice. Pulm Pharmacol Ther. 44:96–105. 2017. View Article : Google Scholar : PubMed/NCBI
24	Li Y, Cai L, Wang H, Wu P, Gu W, Chen Y, Hao H, Tang K, Yi P, Liu M, et al: Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2. Oncogene. 30:3887–3899. 2011. View Article : Google Scholar : PubMed/NCBI
25	Lee HY, Kim H, Lee SY, Jung YS, Kim SD and Bae YS: A membrane-tethering pepducin that inhibits formyl peptide receptor 2-induced signaling. Pharmazie. 69:293–296. 2014.PubMed/NCBI
26	Pei Z, Li H, Guo Y, Jin Y and Lin D: Sodium selenite inhibits the expression of VEGF, TGFbeta(1) and IL-6 induced by LPS in human PC3 cells via TLR4-NF-(K)B signaling blockage. Int Immunopharmacol. 10:50–56. 2010. View Article : Google Scholar : PubMed/NCBI
27	Wang ZS, Chen LZ, Zhou HP, Liu XH and Chen FH: Diarylpentadienone derivatives (curcumin analogues): Synthesis and anti-inflammatory activity. Bioorg Med Chem Lett. 27:1803–1807. 2017. View Article : Google Scholar : PubMed/NCBI
28	Wang YW, Zhang HH, Wang YL, Guo SS, Li T, Chen L, Zhuang SX, Zhou ZM and Yang WP: Effect of huangqin tang on the regulatory NF-κB p65 signal pathway in rats with ulcerative colitis. Yao Xue Xue Bao. 50:21–27. 2015.(In Chinese). PubMed/NCBI
29	Vitaliti G, Pavone P, Mahmood F, Nunnari G and Falsaperla R: Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: An update of new immune-modulating approaches. Hum Vaccin Immunother. 10:868–875. 2014. View Article : Google Scholar : PubMed/NCBI